Mycobacterium tuberculosis (M. tuberculosis) is the causative agent of human tuberculosis. The continued evolution of M. tuberculosis under drug-selective pressure has facilitated the emergence of drug-resistant strains, that endanger human health.
Currently, it is hoped that screening for inhibitory strains will lead to the discovery of drugs that inhibit M. Tuberculosis. CD BioSciences provides an advanced technology platform for Bifidobacterium breve-based pathogenic bacteria screening service. Our MicroScanTM technology platform is development to meet customer's personalized customization needs.
Overview of M. tuberculosis
- Basics about M. tuberculosis
M. tuberculosis is weakly Gram-positive strain due to an unusual waxy coating on its cell surface that is not susceptible to Gram staining. it was first discovered in 1882 by Robert Koch, M. tuberculosis.
- Toxicity Factors of M. tuberculosis
The virulence factors of M. tuberculosis include cord factor, tuberculin, capsule, etc. M. tuberculosis invades susceptible organisms through the respiratory tract, gastrointestinal tract or skin injury, causing tuberculosis in a variety of tissues and organs. Currently, a combination of drugs is used to treat infections caused by M. tuberculosis.
Types of Diseases Caused by M. tuberculosis
 Occult Bacteraemia |
 Bone Tuberculosis |
 Renal Tuberculosis |
| Small amounts of M. tuberculosis enter the bloodstream and spread throughout the body, and the symptoms of the disease are not obvious. | Bone tuberculosis, which is not a complication of pulmonary tuberculosis, is an occult infection of the M. tuberculosis. | Renal tuberculosis occurs mostly in adults. The incidence is slightly higher in men than in women. |
 Pulmonary Tuberculosis |
 Tuberculous Pleurisy |
 Intestinal Tuberculosis |
| Tuberculosis is the most common disease caused by M. tuberculosis. When humans inhale air containing germs, the bacteria reach the lungs via the respiratory tract and cause infection. | Tuberculous pleurisy often occurs as a complication of tuberculosis. It is an acute, subacute, chronic or recurrent inflammatory disease. | Intestinal tuberculosis is a chronic and specific infection of the intestinal tract. The infection can be transmitted through the gastrointestinal tract, the bloodstream, and through tuberculosis in adjacent organs. |
Our Service
CD BioSciences provides pathogenic bacteria screening service using M. tuberculosis as an indicator strain. Our MicroScanTM technology platform can discovery bacteria strains that Inhibit the growth of the indicator strain, which perhaps generate new antibacterial drugs as antibiotics. This platform provides a new approach for screening and detecting microbial interactions and it can be applied to any microbial flora.
- Single Bacteria Strain Discovery
Identifying single bacterial stains that can be mixed with M. tuberculosis - Combination of Bacteria Strains Discovery
Identifying a mixture of bacteria strains that can be mixed with M. tuberculosis
Features of Our Services
- Advanced Technology
CD BioSciences has a rich resource of pathogenic bacteria strains and a professional laboratory that strongly supports scientific research.
- Fast Delivery
You are guaranteed to submit your results within your expected time.
- Comprehensive Service
Professional pre-sales, in-sales and after-sales service to answer your questions in detail.
CD BioSciences is committed to providing professional and efficient service to our customers around the world. As a pioneer in biotechnology, CD BioSciences has grown into one of the largest independent biotechnology companies in the world. If you would like more information, please contact us.